Researchers at the Ohio State University have designed and tested a vaccine that uses a unique bilateral technique to conquer the Zika virus.
Zika virus could be transmitted sexually. This discovery has been documented already, but the risks were not well understood. It was unknown whether other flaviviruses could be transmitted in the same manner.
A new study by University of Alberta scientists found major potential in a fresh and potent class of chemical compounds for treating Zika virus and respiratory syncytial virus (RSV).
Using nanotechnology, the research team developed tiny platinum nanomotors to target Zika and microbeads to bind the virus. When they are added to a sample containing Zika, a 3D complex is formed which moves in the presence of hydrogen peroxide. This unique motion signal can be perceived using a smartphone by attaching it to a cost-effective optical device. The 3D Zika complex moves rapidly compared to the slower movement of other non-target viruses.
Roche has secured approval from the US Food and Drug Administration (FDA) for its cobas Zika test to detect RNA of the Zika virus in human plasma samples.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.